CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

GW4869 2HCl 10mg  | ≥98%

CSNpharm

GW4869 2HCl is a cell permeable, selective and non-competitve inhibitor of N-SMase (neutral sphingomyelinase), which is important in the metabolism of sphingomyelin producing ceramide and phosphocholine and in cell signaling and regulation.

More Information Supplier Page

GW4869 2HCl 2mg  | ≥98%

CSNpharm

GW4869 2HCl is a cell permeable, selective and non-competitve inhibitor of N-SMase (neutral sphingomyelinase), which is important in the metabolism of sphingomyelin producing ceramide and phosphocholine and in cell signaling and regulation.

More Information Supplier Page

GW4869 2HCl 50mg  | ≥98%

CSNpharm

GW4869 2HCl is a cell permeable, selective and non-competitve inhibitor of N-SMase (neutral sphingomyelinase), which is important in the metabolism of sphingomyelin producing ceramide and phosphocholine and in cell signaling and regulation.

More Information Supplier Page

GW4869 2HCl 25mg  | ≥98%

CSNpharm

GW4869 2HCl is a cell permeable, selective and non-competitve inhibitor of N-SMase (neutral sphingomyelinase), which is important in the metabolism of sphingomyelin producing ceramide and phosphocholine and in cell signaling and regulation.

More Information Supplier Page

GW4869 2HCl 5mg  | ≥98%

CSNpharm

GW4869 2HCl is a cell permeable, selective and non-competitve inhibitor of N-SMase (neutral sphingomyelinase), which is important in the metabolism of sphingomyelin producing ceramide and phosphocholine and in cell signaling and regulation.

More Information Supplier Page

GW4869 2HCl 100mg  | ≥98%

CSNpharm

GW4869 2HCl is a cell permeable, selective and non-competitve inhibitor of N-SMase (neutral sphingomyelinase), which is important in the metabolism of sphingomyelin producing ceramide and phosphocholine and in cell signaling and regulation.

More Information Supplier Page

GW627368 1mg  | ≥99%

CSNpharm

GW627368 is a potent and selective competitive antagonist of prostanoid EP4 receptor (Ki= 100 nM) with additional human TP receptor affinity (Ki= 150 nM).

More Information Supplier Page

GW627368 25mg  | ≥99%

CSNpharm

GW627368 is a potent and selective competitive antagonist of prostanoid EP4 receptor (Ki= 100 nM) with additional human TP receptor affinity (Ki= 150 nM).

More Information Supplier Page

GW627368 10mg  | ≥99%

CSNpharm

GW627368 is a potent and selective competitive antagonist of prostanoid EP4 receptor (Ki= 100 nM) with additional human TP receptor affinity (Ki= 150 nM).

More Information Supplier Page

GW627368 5mg  | ≥99%

CSNpharm

GW627368 is a potent and selective competitive antagonist of prostanoid EP4 receptor (Ki= 100 nM) with additional human TP receptor affinity (Ki= 150 nM).

More Information Supplier Page

GW9508 10mg  | ≥99%

CSNpharm

GW9508 is selective FFA1 (GPR40) agonist with pEC50 of 7.32 and stimulates insulin secretion in a glucose-sensitive manner.

More Information Supplier Page

GW9508 100mg  | ≥99%

CSNpharm

GW9508 is selective FFA1 (GPR40) agonist with pEC50 of 7.32 and stimulates insulin secretion in a glucose-sensitive manner.

More Information Supplier Page

GW9508 50mg  | ≥99%

CSNpharm

GW9508 is selective FFA1 (GPR40) agonist with pEC50 of 7.32 and stimulates insulin secretion in a glucose-sensitive manner.

More Information Supplier Page

GW9508 25mg  | ≥99%

CSNpharm

GW9508 is selective FFA1 (GPR40) agonist with pEC50 of 7.32 and stimulates insulin secretion in a glucose-sensitive manner.

More Information Supplier Page

GW9508 5mg  | ≥99%

CSNpharm

GW9508 is selective FFA1 (GPR40) agonist with pEC50 of 7.32 and stimulates insulin secretion in a glucose-sensitive manner.

More Information Supplier Page

GW9662 25mg  | ≥99%

CSNpharm

GW9662 selectively antagonizes PPARγ with IC50 of 3.3 nM. It can inhibit the growth of mammary cancer cells.

More Information Supplier Page

GW9662 1mg  | ≥99%

CSNpharm

GW9662 selectively antagonizes PPARγ with IC50 of 3.3 nM. It can inhibit the growth of mammary cancer cells.

More Information Supplier Page

GW9662 100mg  | ≥99%

CSNpharm

GW9662 selectively antagonizes PPARγ with IC50 of 3.3 nM. It can inhibit the growth of mammary cancer cells.

More Information Supplier Page

GW9662 50mg  | ≥99%

CSNpharm

GW9662 selectively antagonizes PPARγ with IC50 of 3.3 nM. It can inhibit the growth of mammary cancer cells.

More Information Supplier Page

GW9662 10mg  | ≥99%

CSNpharm

GW9662 selectively antagonizes PPARγ with IC50 of 3.3 nM. It can inhibit the growth of mammary cancer cells.

More Information Supplier Page

GW9662 5mg  | ≥99%

CSNpharm

GW9662 selectively antagonizes PPARγ with IC50 of 3.3 nM. It can inhibit the growth of mammary cancer cells.

More Information Supplier Page

Gypenoside XLIX 10mg  | ≥98%

CSNpharm

Gypenoside XLIX, a dammarane-type glycoside, is a prominent component of G. pentaphyllum. Gypenoside XLIX is a selective peroxisome proliferator-activated receptor (PPAR)-alpha activator and inhibits cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) overexpression and hyperactivity in human endothelial cells.

More Information Supplier Page

Gypenoside XLIX 25mg  | ≥98%

CSNpharm

Gypenoside XLIX, a dammarane-type glycoside, is a prominent component of G. pentaphyllum. Gypenoside XLIX is a selective peroxisome proliferator-activated receptor (PPAR)-alpha activator and inhibits cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) overexpression and hyperactivity in human endothelial cells.

More Information Supplier Page

Gypenoside XLIX 5mg  | ≥98%

CSNpharm

Gypenoside XLIX, a dammarane-type glycoside, is a prominent component of G. pentaphyllum. Gypenoside XLIX is a selective peroxisome proliferator-activated receptor (PPAR)-alpha activator and inhibits cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) overexpression and hyperactivity in human endothelial cells.

More Information Supplier Page

H 89 2HCl 10mg  | ≥99%

CSNpharm

H 89 2HCl is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM. It also shows weak inhibition on PKG, PKC, CK1, CK2 and others kinases.

More Information Supplier Page

H 89 2HCl 100mg  | ≥99%

CSNpharm

H 89 2HCl is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM. It also shows weak inhibition on PKG, PKC, CK1, CK2 and others kinases.

More Information Supplier Page

H 89 2HCl 50mg  | ≥99%

CSNpharm

H 89 2HCl is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM. It also shows weak inhibition on PKG, PKC, CK1, CK2 and others kinases.

More Information Supplier Page

H 89 2HCl 5mg  | ≥99%

CSNpharm

H 89 2HCl is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM. It also shows weak inhibition on PKG, PKC, CK1, CK2 and others kinases.

More Information Supplier Page